4. SAFETY TRAINING In the following table, provide the names of Drexel University personnel involved in this study (including the Principal Investigator). All personnel must have completed BioRAFT-based laboratory safety training within the last 12 months. Please note that: Because the PI is responsible for all biosafety aspects of the project, the PI must complete all relevant laboratory training. When entering information in the to be be specific as to the major tasks “Tasks Performed” column, to be performed. For example, a project involving the collection of patient blood samples for and as tasks. cytokine analysis might include “blood collection,” “sample processing,” “ELISAs” The training completion date should be entered in the mm-dd-yyyy format. If the completed through BioRAFT within the last 12 “Shipping Biological Materials” course was months, check the appropriate box(es) for each person listed in the table. To complete laboratory safety training, go to and log in using your DrexelOne user ID and password. (Please note: If you are using MS Word on a PC, you will likely need to copy the link directly into your web browser. This is a MS Word issue with no work-around.) Tasks to be performed Name of investigator, (e.g., sample collection, Date of BioRAFT Biohazard Material student, or coordinator processing/shipping) training Shipping Training PI 5. STUDY INFORMATION Answer the following questions about studies involving laboratory analyses or experimentation involving specimens collected from human study participants. a. Describe the specimens to be collected from study participants. b. Will the specimens be collected from study participants known or demonstrated to be infected with human pathogens? If your answer is Yes, list the Yes No pathogen(s). Note: All human specimens must be handled using Standard Precautions regardless of the participant pathogen status. c. Will the specimens be tested after collection for the presence of selected human pathogens? If your answer is Yes, list the pathogens to be detected. Yes No All human specimens must be handled using Standard Precautions Note: regardless of the pathogen testing results. d. If you answered to either question 5b or 5c above, indicate the Risk Groups(s) of the Yes
4. SAFETY TRAINING In the following table, provide the names of Drexel University personnel involved in this study (including the Principal Investigator). All personnel must have completed BioRAFT-based laboratory safety training within the last 12 months. Please note that: Because the PI is responsible for all biosafety aspects of the project, the PI must complete all relevant laboratory training. When entering information in the “Tasks to be Performed” column, be specific as to the major tasks to be performed. For example, a project involving the collection of patient blood samples for cytokine analysis might include “blood collection,” “sample processing,” and “ELISAs” as tasks. The training completion date should be entered in the mm-dd-yyyy format. If the “Shipping Biological Materials” course was completed through BioRAFT within the last 12 months, check the appropriate box(es) for each person listed in the table. To complete laboratory safety training, go to and log in using your DrexelOne user ID and password. (Please note: If you are using MS Word on a PC, you will likely need to copy the link directly into your web browser. This is a MS Word issue with no work-around.) Name of investigator, student, or coordinator Tasks to be performed (e.g., sample collection, processing/shipping) Date of BioRAFT training Biohazard Material Shipping Training PI 5. STUDY INFORMATION Answer the following questions about studies involving laboratory analyses or experimentation involving specimens collected from human study participants. a. Describe the specimens to be collected from study participants. b. Will the specimens be collected from study participants known or demonstrated to be infected with human pathogens? If your answer is Yes, list the pathogen(s). Note: All human specimens must be handled using Standard Precautions regardless of the participant pathogen status. Yes No c. Will the specimens be tested after collection for the presence of selected human pathogens? If your answer is Yes, list the pathogens to be detected. Note: All human specimens must be handled using Standard Precautions regardless of the pathogen testing results. Yes No d. If you answered Yes to either question 5b or 5c above, indicate the Risk Groups(s) of the
Form_F_Human_Specimens_Registration_Form2017a.docx